BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9645098)

  • 1. [Saposin C deficiency].
    Sano A
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):420-2. PubMed ID: 9645098
    [No Abstract]   [Full Text] [Related]  

  • 2. [Saposin B deficiency].
    Kotani Y; Sano A
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):417-9. PubMed ID: 9645097
    [No Abstract]   [Full Text] [Related]  

  • 3. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
    Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
    Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prosaposin deficiency].
    Kondoh K; Sano A
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):414-6. PubMed ID: 9645096
    [No Abstract]   [Full Text] [Related]  

  • 5. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
    Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
    Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
    Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Deficiency of arylsulfatase A activity as a basis of metachromatic leucodystrophy].
    Lugowska A; Tylki-Szymańska A
    Postepy Biochem; 1996; 42(3):284-9. PubMed ID: 9036380
    [No Abstract]   [Full Text] [Related]  

  • 8. Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D.
    Ponting CP
    Protein Sci; 1994 Feb; 3(2):359-61. PubMed ID: 8003971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sphingolipid activator protein deficiency].
    Suzuki Y
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):471-4. PubMed ID: 11031998
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow transplantation in metachromatic leukodystrophy caused by saposin-B deficiency: a case report with a 3-year follow-up period.
    Landrieu P; Blanche S; Vanier MT; Metral S; Husson B; Sandhoff K; Fischer A
    J Pediatr; 1998 Jul; 133(1):129-32. PubMed ID: 9672525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saposin B deficiency as a cause of adult-onset metachromatic leukodystrophy.
    Fenu S; Castellotti B; Farina L; Cavallaro T; Di Bella D; Benzoni C; Gellera C; Pareyson D; Taroni F; Salsano E
    Neurology; 2019 Aug; 93(7):310-312. PubMed ID: 31289144
    [No Abstract]   [Full Text] [Related]  

  • 12. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
    Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
    Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of human saposin C: pH-dependent interaction with phospholipid vesicles.
    de Alba E; Weiler S; Tjandra N
    Biochemistry; 2003 Dec; 42(50):14729-40. PubMed ID: 14674747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activator protein-deficient metachromatic leukodystrophy: diagnosis in leukocytes using immunologic methods.
    Fujibayashi S; Inui K; Wenger DA
    J Pediatr; 1984 May; 104(5):739-42. PubMed ID: 6716221
    [No Abstract]   [Full Text] [Related]  

  • 15. Fusogenic domain and lysines in saposin C.
    Qi X; Chu Z
    Arch Biochem Biophys; 2004 Apr; 424(2):210-8. PubMed ID: 15047193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolutionary history of prosaposin: two successive tandem-duplication events gave rise to the four saposin domains in vertebrates.
    Hazkani-Covo E; Altman N; Horowitz M; Graur D
    J Mol Evol; 2002 Jan; 54(1):30-4. PubMed ID: 11734895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human saposins by NMR spectroscopy.
    John M; Wendeler M; Heller M; Sandhoff K; Kessler H
    Biochemistry; 2006 Apr; 45(16):5206-16. PubMed ID: 16618109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy.
    Zhang XL; Rafi MA; DeGala G; Wenger DA
    Hum Genet; 1991 Jun; 87(2):211-5. PubMed ID: 2066109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations in arylsulfatase A gene in three Ukrainian families with metachromatic leukodystrophy.
    Olkhovich NV; Takamura N; Pichkur NA; Gorovenko NG; Aoyagi K; Yamashita S
    Mol Genet Metab; 2003 Nov; 80(3):360-3. PubMed ID: 14680985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of the postulated intramolecular sphingolipid activator protein domain of human acid sphingomyelinase.
    Kölzer M; Ferlinz K; Bartelsen O; Hoops SL; Lang F; Sandhoff K
    Biol Chem; 2004 Dec; 385(12):1193-5. PubMed ID: 15653433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.